Casdin Capital as of Sept. 30, 2024
Portfolio Holdings for Casdin Capital
Casdin Capital holds 35 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 14.5 | $218M | 8.7M | 25.04 | |
| Revolution Medicines (RVMD) | 12.4 | $187M | 4.1M | 45.35 | |
| Genedx Holdings Corp Com Cl A (WGS) | 9.9 | $149M | 3.5M | 42.44 | |
| D Fluidigm Corp Del (LAB) | 9.2 | $138M | 71M | 1.93 | |
| Sarepta Therapeutics (SRPT) | 8.9 | $134M | 1.1M | 124.89 | |
| Illumina (ILMN) | 6.5 | $98M | 750k | 130.41 | |
| Avidity Biosciences Ord (RNA) | 6.4 | $96M | 2.1M | 45.93 | |
| Relay Therapeutics (RLAY) | 4.4 | $66M | 9.3M | 7.08 | |
| Alnylam Pharmaceuticals (ALNY) | 3.1 | $47M | 170k | 275.03 | |
| EXACT Sciences Corporation (EXAS) | 3.0 | $44M | 650k | 68.12 | |
| Intellia Therapeutics (NTLA) | 2.7 | $41M | 2.0M | 20.55 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.0 | $31M | 700k | 43.89 | |
| Blueprint Medicines (BPMC) | 2.0 | $30M | 326k | 92.50 | |
| Denali Therapeutics (DNLI) | 1.9 | $29M | 990k | 29.13 | |
| Codexis (CDXS) | 1.7 | $25M | 8.1M | 3.08 | |
| Veracyte (VCYT) | 1.5 | $23M | 666k | 34.04 | |
| Neurogene (NGNE) | 1.5 | $22M | 525k | 41.96 | |
| Verve Therapeutics (VERV) | 1.3 | $19M | 4.0M | 4.84 | |
| Beam Therapeutics (BEAM) | 1.3 | $19M | 775k | 24.50 | |
| Tenaya Therapeutics (TNYA) | 0.9 | $13M | 6.7M | 1.93 | |
| 4d Molecular Therapeutics In (FDMT) | 0.8 | $12M | 1.2M | 10.81 | |
| 2seventy Bio Common Stock | 0.6 | $9.4M | 2.0M | 4.72 | |
| Tango Therapeutics (TNGX) | 0.6 | $9.2M | 1.2M | 7.70 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $9.1M | 475k | 19.25 | |
| Guardant Health (GH) | 0.5 | $8.0M | 350k | 22.94 | |
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $5.7M | 297k | 19.14 | |
| Century Therapeutics (IPSC) | 0.4 | $5.5M | 3.2M | 1.71 | |
| Grail (GRAL) | 0.3 | $4.8M | 350k | 13.76 | |
| Absci Corp (ABSI) | 0.2 | $3.7M | 973k | 3.82 | |
| Pacific Biosciences of California (PACB) | 0.1 | $1.8M | 1.0M | 1.70 | |
| Prime Medicine (PRME) | 0.1 | $1.4M | 367k | 3.87 | |
| Exscientia Ads (EXAI) | 0.1 | $1.0M | 214k | 4.88 | |
| Monte Rosa Therapeutics (GLUE) | 0.0 | $456k | 86k | 5.30 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $297k | 37k | 8.15 | |
| Kronos Bio | 0.0 | $124k | 124k | 1.00 |
